Tools
Tools
Onken, Annette, Moyo, Sabrina, Miraji, Mohammed Khamis, Bohlin, Jon, Marijani, Msafiri, Manyahi, Joel, Kibwana, Kibwana Omar, Müller, Fredrik, Jenum, Pål A., Abeid, Khamis Ali, Reimers, Marianne, Langeland, Nina, Mørch, Kristine and Blomberg, Bjørn (2024) 'Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar'. PLoS Neglected Tropical Diseases, Vol 18, Issue 4, e0012132.
|
Text
pntd.0012132.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Background: Typhoid fever is a common cause of febrile illness in low- and middle-income countries. While multidrug-resistant (MDR) Salmonella Typhi (S. Typhi) has spread globally, fluoroquinolone resistance has mainly affected Asia.
Methods: Consecutively, 1038 blood cultures were obtained from patients of all age groups with fever and/or suspicion of serious systemic infection admitted at Mnazi Mmoja Hospital, Zanzibar in 2015–2016. S. Typhi were analyzed with antimicrobial susceptibility testing and with short read (61 strains) and long read (9 strains) whole genome sequencing, including three S. Typhi strains isolated in a pilot study 2012–2013.
Results: Sixty-three S. Typhi isolates (98%) were MDR carrying blaTEM-1B, sul1 and sul2, dfrA7 and catA1 genes. Low-level ciprofloxacin resistance was detected in 69% (43/62), with a single gyrase mutation gyrA-D87G in 41 strains, and a single gyrA-S83F mutation in the non-MDR strain. All isolates were susceptible to ceftriaxone and azithromycin. All MDR isolates belonged to genotype 4.3.1 lineage I (4.3.1.1), with the antimicrobial resistance determinants located on a composite transposon integrated into the chromosome. Phylogenetically, the MDR subgroup with ciprofloxacin resistance clusters together with two external isolates.
Conclusions: We report a high rate of MDR and low-level ciprofloxacin resistant S. Typhi circulating in Zanzibar, belonging to genotype 4.3.1.1, which is widespread in Southeast Asia and African countries and associated with low-level ciprofloxacin resistance. Few therapeutic options are available for treatment of typhoid fever in the study setting. Surveillance of the prevalence, spread and antimicrobial susceptibility of S. Typhi can guide treatment and control efforts.
| Item Type: | Article | ||||
|---|---|---|---|---|---|
| Subjects: | QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified. WC Communicable Diseases > Infection. Bacterial Infections > Enteric Infections > WC 269 Salmonella infections WC Communicable Diseases > Infection. Bacterial Infections > Enteric Infections > WC 270 Typhoid fever |
||||
| Repository link: |
|
||||
| Faculty: Department: | Clinical Sciences & International Health > Clinical Sciences Department | ||||
| Digital Object Identifer (DOI): | https://doi.org/10.1371/journal.pntd.0012132 | ||||
| SWORD Depositor: | JISC Pubrouter | ||||
| Depositing User: | JISC Pubrouter | ||||
| Date Deposited: | 07 May 2024 12:43 | ||||
| Last Modified: | 07 May 2024 12:50 | ||||
| URI: | https://archive.lstmed.ac.uk/id/eprint/24475 |
Statistics
Actions (login required)
 |
Edit Item |